Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Zelira Therapeutics ( (AU:ZLD) ) has issued an announcement.
Zelira Therapeutics Limited announced a proposed issue of 550,000 ordinary fully paid securities, with the issue date set for March 31, 2025. This move is part of the company’s strategic efforts to enhance its financial position and support its ongoing projects, potentially impacting its market presence and stakeholder interests positively.
More about Zelira Therapeutics
Zelira Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of cannabinoid-based medicines. The company is involved in creating therapeutic solutions for various medical conditions, leveraging its expertise in cannabinoid research and product development.
YTD Price Performance: -22.34%
Average Trading Volume: 380
Technical Sentiment Signal: Buy
Current Market Cap: $3.43M
For detailed information about ZLD stock, go to TipRanks’ Stock Analysis page.